Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

448 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

NCT01026415

Conditions
Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
  • Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
View Trial Details
Completed

Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL

NCT00655837

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Colorado Aurora, Colorado, United States
  • Oncology Specialists Park Ridge, Illinois, United States
View Trial Details
Completed

A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT00283114

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +16 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Cancer Care Specialists of Central Illinois Decatur, Illinois, United States
  • Indiana Oncology-Hematology Consultants Indianapolis, Indiana, United States
  • University of Massachusetts Medical Center Worcester, Massachusetts, United States
View Trial Details
Completed

A Safety Study in Patients With Chronic Lymphocytic Leukemia

NCT00283101

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Weill Medical College/Cornell University New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

NCT00430846

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Washington University St Louis, Missouri, United States
  • Weill Cornell Medical College New York, United States
  • University of Texas/MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

NCT00079716

Conditions
Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
Locations
  • James R. Berenson M.D., Inc. West Hollywood, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cornell University New York, United States
View Trial Details
Completed

A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma

NCT01060904

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • UNC Lineberger Comprehensive Cancer Center / University of North Carolina Chapel Hill, North Carolina, United States
  • MD Anderson Cancer Center / University of Texas Houston, Texas, United States
  • British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma

NCT00103779

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford University Stanford, California, United States
  • University of Miami Miami, Florida, United States
  • Cornell University New York, United States
View Trial Details
Completed

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

NCT01026233

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Miami Hospital and Clinics, Miller School of Medicine Miami, Florida, United States
View Trial Details
Completed

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

NCT01344681

Conditions
Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations
  • Dong-A Medical Center Busan, South Korea
  • Severance Hospital Seoul, South Korea
  • Korea University Guro Hospital Seoul, South Korea
  • ASAN Medical Center Seoul, South Korea
View Trial Details

Related conditions